Surgery Partners (SGRY) reported Q3 adjusted net income Tuesday of $0.19 per diluted share, unchanged from a year earlier.
Analysts polled by Capital IQ expected $0.26.
Revenue for the quarter ended Sept. 30 was $770.4 million, up from $674.1 million a year earlier.
Analysts surveyed by Capital IQ expected $769.8 million.
For 2024, the healthcare services company said it continues to expect revenue of greater than $3.08 billion. Analysts polled by Capital IQ expect $3.09 billion.
Shares of Surgery Partners fell more than 12% in recent Tuesday premarket activity.